Researchers at The University of Texas MD Anderson Cancer Center have discovered important mechanisms of drug resistance and metastasis in triple-negative breast cancer. Gloria Echeverria, Ph.D., instructor in Experimental Radiation Oncology, presents these findings today at the 2019 San Antonio Breast Cancer Symposium, which provide possible leads for improving breast cancer treatment.
Triple-negative breast cancer is extremely...
MD Anderson researchers have identified early genomic events that may lead to malignant transformation. They’ve found that tissue adjacent...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer globally. Even with multimodality treatment, including surgery...
Immunology research to investigate the mechanisms of a new aerosol treatment, which induces an innate immune response to protect against pathogens that cause pneumonia, asthma, and other lung diseases, has earned major funding from the National Heart, Lung, and Blood Institute.
“This research will help protect patients who are most vulnerable to pneumonia, especially patients with cancer,” said Scott Evans, M.D., the principal...
Unresectable pancreatic cancer is usually fatal because other treatments, such as radiation therapy, cannot be used. Radiation therapy causes...
Glioblastoma is the most common, aggressive and deadly form of brain cancer. Median overall survival for primary glioblastoma is 14.6 months...